Sheri Dodds
Family Health · Lancaster, OHNPI 1194782987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Astellas Pharma US Inc at 26.1% of the total.
Across 132 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$606
- Amgen$364
- Boehringer Ingelheim$230
- Novo Nordisk$164
- AbbVie$129
- Bayer$100
- plus $726 from 18 others
What the payments were for
- Food & beverage$2,13592%
- Education$1858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 22 | $606 |
| Amgen | 28 | $364 |
| Boehringer Ingelheim | 16 | $230 |
| Novo Nordisk | 11 | $164 |
| AbbVie | 7 | $129 |
| Bayer | 6 | $100 |
| Grifols USA, LLC | 6 | $99 |
| Exact Sciences | 4 | $65 |
| Pfizer | 3 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $58 |
| Amarin Pharma, Inc. | 3 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| Johnson & Johnson | 3 | $47 |
| GSK | 3 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Merck | 2 | $31 |
| Lilly USA, LLC | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| AstraZeneca | 1 | $15 |
| Abbott | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$121
How this compares
Too few family health providers in Ohioto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 11 | $4,783 |
| AlyacenNorethindrone-Ethin. Estradiol | 18 | $460 |
| Medroxyprogesterone Acetate | 13 | $411 |
| Junel FeNorethindrone-E.Estradiol-Iron | 11 | $170 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $62 | $4,78311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few family health providers in Ohioon file to place this against a meaningful peer group, so we don't.
Other family health in Lancaster
- Fred WagshulDayton$5K
- Lisa RitenourCanton$2K
- Vicki DelanyDublin$990
- Annette SaveskiMansfield$565
- Juanita KrisherDayton$479
- Chasady FreezeBowling Green$405
- Elizabeth MitchellCincinnati$318
- Suvarnamala PushkaranMiddletown$150
- Kelley RhoadesZanesville$81
- Kirsten DodsonColumbus$68
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.